Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 275 No 7372 p530
22 October 2005


Society summary


Council seeks end to ceiling on attendance fee

The Council of the Royal Pharmaceutical Society has decided to seek the removal from the Byelaws of a ceiling on the fee payable for attendance at meetings of the Council and its committees. It did so at the October Council meeting at the suggestion of advisers to the Privy Council.

The Council was reminded that earlier in the year it had agreed to seek Privy Council approval for a proposal to raise the ceiling from £200 to £300 (PJ, 16 July 2005, p100). No comment on the proposal had been received from members during the 60-day consultation period and the deputy clerk of the Privy Council had indicated that advisers would recommend the Privy Council to approve the proposal if it received little or no opposition. However, the advisers also took the view that the level of fees payable to Council members should be a matter for the Society’s own members and not something over which the Privy Council should exercise detailed control. The deputy clerk suggested that the Council should consider a further draft Byelaw amendment to that effect.

The Council therefore agreed not to proceed with the proposal to raise the limit but instead to seek an amendment to the effect that Council members “shall be entitled to receive a reasonable fee, which shall be -determined by the Council from time to time by resolution … for attending any meeting of the Council …”.

The Secretary and Registrar said that there would still be a requirement to gazette the changes and for the Council to announce the fee each year. The Council would consider the fee normally on an annual basis.

The proposed amendment is set out in an Official Notice this week (p534).

Back to Top


©The Pharmaceutical Journal